Reuters - Health Report

Click to View in Browser

Tuesday, November 21, 2017

Counting the costs: U.S. hospitals feeling the pain of physician burnout

ANN ARBOR, Mich. (Reuters) - Dr. Brian Halloran, a vascular surgeon at St. Joseph Mercy Ann Arbor, starts planning his garden long before spring arrives in southeast Michigan.

Britain says Canada's Concordia overcharging health service for thyroid drug

LONDON (Reuters) - Drug company Concordia overcharged Britain's health service millions of pounds for an essential thyroid drug by abusing its position as the only supplier, the country's Competition and Markets Authority said on Tuesday.

2.5 million Yemenis now lack access to clean water: Red Cross

GENEVA (Reuters) - The capital Sanaa and al-Bayda have joined the list of Yemen cities without clean water due to the blockade by a Saudi-led coalition which has cut off supplies of fuel for pumping, the International Committee of the Red Cross (ICRC) said on Monday.

Roche stock up $12 billion on cancer, hemophilia trials; rivals hit

ZURICH (Reuters) - Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker is counting on to offset shrinking revenue from older medicines.

HCR ManorCare gets respite from dropped Medicare fraud lawsuit

CHICAGO (Reuters) - The U.S. Justice Department withdrew a Medicare fraud lawsuit against HCR ManorCare, removing a cloud over one the largest U.S. nursing home chains as it nears a deadline to settle a legal dispute with its landlord.

U.S. judge rejects plea deal with Novelion's Aegerion

BOSTON (Reuters) - A judge on Monday rejected a plea deal that was part of Aegerion Pharmaceuticals Inc's recent agreement to pay $40.1 million to resolve U.S. probes of its marketing of a cholesterol drug, saying it was "not in the public interest."

Reimbursement cuts on lab tests pressure U.S. lab firm shares

(Reuters) - A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as $3 billion over five years, but hurt margins of U.S. laboratory companies.

New ARV drugs, early diagnosis key to beating AIDS epidemic: UNAIDS

CAPE TOWN (Reuters) - Developing new antiretroviral (ARV) drugs and using technology for early diagnosis are among steps needed to sustain momentum in fighting HIV/AIDS and ending the disease as a public health threat by 2030, UNAIDS said in a report on Monday.

Substituting methadone for opioids could save billions

(Reuters Health) - Policymakers and insurers have been pushing people addicted to opioids into abstinence-based detox programs, but a new study concludes that methadone and similar drug-maintenance treatments save lives and money.

Help obese kids avoid weight stigma, doctors advise

(Reuters Health) - Shaming kids about their weight doesn’t encourage them to shed excess pounds, U.S. doctors warn.